Description

This research blend pairs Fragment 176-191 with Mod GRF 1-29 and Ipamorelin in a single lyophilised vial. Mod GRF 1-29 stimulates GH release via GHRH receptors, Ipamorelin acts through ghrelin receptors, and Fragment 176-191 targets adipose lipolysis. Together they offer researchers a multifaceted tool for studying GH secretion and fat metabolism simultaneously. Supplied by Nexopep with third-party purity verification. For in-vitro research only.

Reviews

There are no reviews yet.

Be the first to review “Fragment 176-191 & Mod GRF 1-29 & Ipamorelin Blend 12mg”

Your email address will not be published. Required fields are marked *